Difference between revisions of "Part:BBa K4147008"
Line 13: | Line 13: | ||
===Characterization of PelB-(CBD)2-DrsB1 Construct with DsbA === | ===Characterization of PelB-(CBD)2-DrsB1 Construct with DsbA === | ||
− | <center>[[File: | + | <center>[[File:PSB1C3-06-DrsB1-DsbA-PelB27_Map.png |300px]]</center> |
<center><b>Figure 1</b>. SnapGene®️ map of BioBrick BBa_K4147008.</center> | <center><b>Figure 1</b>. SnapGene®️ map of BioBrick BBa_K4147008.</center> | ||
===REFERENCES=== | ===REFERENCES=== |
Revision as of 22:09, 9 October 2022
PelB-(CBD)2-DrsB1 Construct with DsbA
This part contains the (CBD)2-DrsB1 expression construct (BBa_K4147001) with co-expression of DsbA (BBa_K4147006) for disulfide bond formation and proper folding of the osmotin protein.
Usage and Biology
The disulfide bonds are essential for structure stabilization and biological functions of these peptides [1].
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 1184
Illegal NgoMIV site found at 1368
Illegal AgeI site found at 392
Illegal AgeI site found at 671 - 1000COMPATIBLE WITH RFC[1000]
Characterization of PelB-(CBD)2-DrsB1 Construct with DsbA
REFERENCES
[1] Zhang QY, Yan ZB, Meng YM, et al. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021;8(1):48. Published 2021 Sep 9. doi:10.1186/s40779-021-00343-2